Acr Open Rheumatology
Overview
Acr Open Rheumatology is a scientific journal, published since 2019 in English. The journal's country of origin is United States.
Details
Details
Abbr.
ACR Open Rheumatol
Start
2019
End
Continuing
Frequency
Monthly
e-ISSN
2578-5745
Country
United States
Language
English
Metrics
Metrics
h-index / Ranks: 11552
24
SJR / Ranks: 2977
1161
CiteScore / Ranks: 5824
4.50
Recent Articles
1.
Szlembarski S, Falaas K, Gertner E
ACR Open Rheumatol
. 2025 Mar;
7(3):e70020.
PMID: 40087995
No abstract available.
2.
Nguyen J, Kim C, Ramirez A, Vogel T
ACR Open Rheumatol
. 2025 Mar;
7(3):e11800.
PMID: 40084498
Objective: The aim of this report is to raise awareness of a rare inborn error of immunity (IEI) that can predispose to inflammatory disease and infection risk by describing a...
3.
Dickinson M, Erridge S, Warner-Levy J, Clarke E, McLachlan K, Coomber R, et al.
ACR Open Rheumatol
. 2025 Mar;
7(3):e70024.
PMID: 40079426
Objective: The study aims to evaluate the clinical outcomes in patients with hypermobility spectrum disorder (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS) with chronic pain following treatment with cannabis-based medicinal products...
4.
Michailidou D, Johansson L, Chapa J, Wang T, Chen J, Lopez J, et al.
ACR Open Rheumatol
. 2025 Mar;
7(3):e70021.
PMID: 40071558
Objective: Platelet activation is thought to participate in polymyalgia rheumatica (PMR) pathogenesis. Upon platelet activation, mitochondria are expelled into the extracellular space. However, whether extracellular mitochondria are present in patients...
5.
White B, Furst D, Frech T, Kuwana M, Hummers L, Stevens W, et al.
ACR Open Rheumatol
. 2025 Mar;
7(3):e70004.
PMID: 40065521
Objectives: The RESOLVE-1 trial of lenabasum in diffuse cutaneous systemic sclerosis (dcSSc) allowed background immunosuppressive therapy (IST) at the discretion of individual investigators, and no significant differences were observed between...
6.
Shimizu T, Endo Y, Umeda M, Kawakami A
ACR Open Rheumatol
. 2025 Mar;
7(3):e70011.
PMID: 40052930
No abstract available.
7.
El Hasbani G, Stern J, Sener U, Thangaiah J, Warrington K
ACR Open Rheumatol
. 2025 Mar;
7(3):e70022.
PMID: 40047035
No abstract available.
8.
Soltani H, Dehghan A
ACR Open Rheumatol
. 2025 Mar;
7(3):e70017.
PMID: 40035457
We report a case of a 34-year-old woman with systemic lupus erythematosus (SLE) who developed thrombocytopenia and was diagnosed with lupus-associated autoimmune myelofibrosis. She was treated with hydroxychloroquine, tofacitinib (5...
9.
Schmukler J, Li T, Block J, Pincus T
ACR Open Rheumatol
. 2025 Mar;
7(3):e70010.
PMID: 40035323
Objective: We aimed to analyze the RheuMetric physician 0 to 10 visual numeric subscale (VNS) estimates of inflammatory activity (DOCINF), organ damage (DOCDAM), and patient distress (DOCDIS) at initial and...
10.
Lee J, Martindale J, Wallace B, Singh N, Makris U, Bynum J
ACR Open Rheumatol
. 2025 Mar;
7(3):e70013.
PMID: 40035233
Background: We evaluated changes in long-term glucocorticoid (GC) use and factors associated with persistent GC use in older adults with late-onset rheumatoid arthritis (LORA). Methods: Using 20% Medicare data from...